Endocannabinoids and the Immune System in Health and Disease (Q38593122)

4 September 2017

Endocannabinoids and the Immune System in Health and Disease (English)

1 reference

4 September 2017

endocannabinoid system

0 references

author name string

Guy A Cabral

series ordinal

1

1 reference

4 September 2017

Gabriela A Ferreira

series ordinal

2

1 reference

4 September 2017

Melissa J Jamerson

series ordinal

3

1 reference

4 September 2017

language of work or name

1 reference

1 January 2015

1 reference

Handbook of experimental pharmacology

4 September 2017

1 reference

4 September 2017

231

1 reference

4 September 2017

185-211

1 reference

Involvement of nitric oxide through endocannabinoids release in microglia activation during the course of CNS regeneration in the medicinal leech

4 September 2017

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

The endocannabinoid 2-arachidonoyl-glycerol activates human neutrophils: critical role of its hydrolysis and de novo leukotriene B4 biosynthesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Temporal variation in CB2R levels following T lymphocyte activation: Evidence that cannabinoids modulate CXCL12-induced chemotaxis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: roles of ERK1/2, JNK, and NF-kappaB.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Endocannabinoid modulation of jejunal afferent responses to LPS

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

2-Arachidonoylglycerol modulates human endothelial cell/leukocyte interactions by controlling selectin expression through CB1 and CB2 receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Molecular cloning of a human cannabinoid receptor which is also expressed in testis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, enhances the adhesion of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

2-Arachidonoylglycerol enhances the phagocytosis of opsonized zymosan by HL-60 cells differentiated into macrophage-like cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Cannabinoid receptor localization in brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Architecture of cannabinoid signaling in mouse retina

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Endocannabinoid degradation inhibition improves neurobehavioral function, blood-brain barrier integrity, and neuroinflammation following mild traumatic brain injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

2-Arachidonoylglycerol Induces the Migration of HL-60 Cells Differentiated into Macrophage-like Cells and Human Peripheral Blood Monocytes through the Cannabinoid CB2 Receptor-dependent Mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: comparison with other eosinophil chemoattractants

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Indirect CB2 receptor and mediator-dependent stimulation of human whole-blood neutrophils by exogenous and endogenous cannabinoids.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

2-Arachidonoylglycerol elicits neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal-cannabidiol-sensitive receptors on microglial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Effects of peripheral cannabinoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

The endogenous cannabinoid 2-arachidonoyl glycerol as in vivo chemoattractant for dendritic cells and adjuvant for Th1 response to a soluble protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Presence and regulation of the endocannabinoid system in human dendritic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB(1) receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Involvement of the endogenous cannabinoid 2 ligand 2-arachidonyl glycerol in allergic inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Anandamide suppresses nitric oxide and TNF-alpha responses to Theiler's virus or endotoxin in astrocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Opposite effects of anandamide and N-arachidonoyl dopamine in the regulation of prostaglandin E and 8-iso-PGF formation in primary glial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Evidence for the involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation in mouse ear.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Endocannabinoids in the immune system and cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Anti-inflammatory effect of the endocannabinoid anandamide in experimental periodontitis and stress in the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Anandamide prior to sensitization increases cell-mediated immunity in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

A COX-2 metabolite of the endogenous cannabinoid, 2-arachidonyl glycerol, mediates suppression of IL-2 secretion in activated Jurkat T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by interferon-β: a longitudinal study in multiple sclerosis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Endocannabinoid system in the adult rat circumventricular areas: an immunohistochemical study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Endocannabinoids limit excessive mast cell maturation and activation in human skin

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

The endocannabinoid 2-arachidonylglycerol decreases the immunological activation of Guinea pig mast cells: involvement of nitric oxide and eicosanoids.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_6

10.1007/978-3-319-20825-1_6

31 March 2020

Identifiers

DOI

1 reference

4 September 2017

1 reference